Stockreport

Clovis off 4% premarket on BofA downgrade [Seeking Alpha]

Clovis Oncology, Inc.  (CLVS) 
Last clovis oncology, inc. earnings: 2/24 04:05 pm Check Earnings Report
PDF Clovis Oncology (NASDAQ: CLVS ) slips   premarket on light volume on the heels of a downgrade to Neutral with a fair value target of $7 (23% upside) (from $13) at [Read more]